Hubei Jumpcan Pharmaceutical Co Ltd (600566) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Hubei Jumpcan Pharmaceutical Co Ltd (600566) has a cash flow conversion efficiency ratio of -0.018x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-243.75 Million ≈ $-35.67 Million USD) by net assets (CN¥13.86 Billion ≈ $2.03 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 600566 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Hubei Jumpcan Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2000–2025)
This chart illustrates how Hubei Jumpcan Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Hubei Jumpcan Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hubei Jumpcan Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Helmerich and Payne Inc
NYSE:HP
|
0.014x |
|
Tianneng Battery Group Co Ltd
SHG:688819
|
0.062x |
|
CIE Automotive S.A.
MC:CIE
|
0.329x |
|
ROCKWOOL International A/S
CO:ROCK-A
|
0.059x |
|
MINISO GRP HLD.ADS/4
F:MIF
|
N/A |
|
Life360, Inc. Common Stock
NASDAQ:LIF
|
0.029x |
|
Changzhou Fusion New Material Co. Ltd. A
SHG:688503
|
N/A |
|
Aperam SA
F:7AA
|
-0.003x |
Annual Cash Flow Conversion Efficiency for Hubei Jumpcan Pharmaceutical Co Ltd (2000–2025)
The table below shows the annual cash flow conversion efficiency of Hubei Jumpcan Pharmaceutical Co Ltd from 2000 to 2025. For the full company profile with market capitalisation and key ratios, see 600566 company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥14.63 Billion ≈ $2.14 Billion |
CN¥1.20 Billion ≈ $175.35 Million |
0.082x | -44.59% |
| 2024-12-31 | CN¥14.73 Billion ≈ $2.15 Billion |
CN¥2.18 Billion ≈ $318.48 Million |
0.148x | -42.96% |
| 2023-12-31 | CN¥13.37 Billion ≈ $1.96 Billion |
CN¥3.46 Billion ≈ $506.89 Million |
0.259x | +12.24% |
| 2022-12-31 | CN¥11.35 Billion ≈ $1.66 Billion |
CN¥2.62 Billion ≈ $383.51 Million |
0.231x | +11.28% |
| 2021-12-31 | CN¥9.13 Billion ≈ $1.34 Billion |
CN¥1.89 Billion ≈ $277.20 Million |
0.207x | -9.61% |
| 2020-12-31 | CN¥7.76 Billion ≈ $1.14 Billion |
CN¥1.78 Billion ≈ $260.72 Million |
0.230x | -34.77% |
| 2019-12-31 | CN¥6.10 Billion ≈ $893.27 Million |
CN¥2.15 Billion ≈ $314.27 Million |
0.352x | +12.35% |
| 2018-12-31 | CN¥5.46 Billion ≈ $798.65 Million |
CN¥1.71 Billion ≈ $250.10 Million |
0.313x | +15.96% |
| 2017-12-31 | CN¥4.40 Billion ≈ $644.12 Million |
CN¥1.19 Billion ≈ $173.95 Million |
0.270x | +9.06% |
| 2016-12-31 | CN¥3.69 Billion ≈ $539.60 Million |
CN¥913.10 Million ≈ $133.61 Million |
0.248x | +4.07% |
| 2015-12-31 | CN¥2.71 Billion ≈ $396.97 Million |
CN¥645.48 Million ≈ $94.45 Million |
0.238x | -11.41% |
| 2014-12-31 | CN¥2.29 Billion ≈ $335.68 Million |
CN¥616.11 Million ≈ $90.16 Million |
0.269x | +7.78% |
| 2013-12-31 | CN¥1.15 Billion ≈ $168.63 Million |
CN¥287.16 Million ≈ $42.02 Million |
0.249x | +352.79% |
| 2012-12-31 | CN¥490.80 Million ≈ $71.82 Million |
CN¥27.01 Million ≈ $3.95 Million |
0.055x | +6950.17% |
| 2011-12-31 | CN¥526.82 Million ≈ $77.09 Million |
CN¥411.24K ≈ $60.18K |
0.001x | -99.21% |
| 2010-12-31 | CN¥520.27 Million ≈ $76.13 Million |
CN¥51.13 Million ≈ $7.48 Million |
0.098x | +924.94% |
| 2009-12-31 | CN¥512.85 Million ≈ $75.05 Million |
CN¥4.92 Million ≈ $719.55K |
0.010x | -78.95% |
| 2008-12-31 | CN¥506.18 Million ≈ $74.07 Million |
CN¥23.05 Million ≈ $3.37 Million |
0.046x | -38.13% |
| 2007-12-31 | CN¥498.83 Million ≈ $72.99 Million |
CN¥36.72 Million ≈ $5.37 Million |
0.074x | +743.02% |
| 2006-12-31 | CN¥485.82 Million ≈ $71.09 Million |
CN¥4.24 Million ≈ $620.77K |
0.009x | -93.38% |
| 2005-12-31 | CN¥480.25 Million ≈ $70.28 Million |
CN¥63.38 Million ≈ $9.27 Million |
0.132x | +265.74% |
| 2004-12-31 | CN¥473.92 Million ≈ $69.35 Million |
CN¥-37.74 Million ≈ $-5.52 Million |
-0.080x | -1755.48% |
| 2003-12-31 | CN¥466.47 Million ≈ $68.26 Million |
CN¥2.24 Million ≈ $328.32K |
0.005x | -89.96% |
| 2002-12-31 | CN¥459.05 Million ≈ $67.17 Million |
CN¥22.00 Million ≈ $3.22 Million |
0.048x | +190.19% |
| 2001-12-31 | CN¥449.57 Million ≈ $65.79 Million |
CN¥7.43 Million ≈ $1.09 Million |
0.017x | -90.25% |
| 2000-12-31 | CN¥140.01 Million ≈ $20.49 Million |
CN¥23.73 Million ≈ $3.47 Million |
0.169x | -- |
About Hubei Jumpcan Pharmaceutical Co Ltd
Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of drugs in China. The company offers Chinese traditional and Western medicines, daily use chemicals, and medicine health products in various formulations. Its products are used in the areas of detoxification, digestive system, pediatric, respiratory system, nervous system, anti-infection, cardiovasc… Read more